← All organizations
Highest phase reached
Phase 3
First clinical trial
Jan 1, 2011Last known activity
Jan 1, 2024
Timeline
2010s
- Jan 1, 2011
Jeroen Bosch Ziekenhuis— Founded
Drugs by trial phase (11 distinct, 9 trials)
Phase 3 (6 own, 0 via acquisition)
Phase 2 (5 own, 0 via acquisition)
Indications
Recent trials (12)
- NCT05725512CollaboratorPhase 2Jan 1, 2024
- NCT05216328CollaboratorPhase 3Dec 2, 2022
- NCT03379909CollaboratorPhase 2Oct 1, 2018
- NCT02384122CollaboratorPhase 2/Phase 3Sep 1, 2015
- NCT01487993CollaboratorPhase 3Aug 1, 2011
- NCT01097265Overall official - principal investigatorPhase 2/Phase 3Jul 1, 2010
- NCT01097265Lead sponsorPhase 2/Phase 3Jul 1, 2010
- NCT01517009Reponsible party - principal investigatorPhase 2Jun 1, 2008
- NCT01517009Lead sponsorPhase 2Jun 1, 2008
- NCT00686985Overall official - principal investigatorPhase 2Sep 1, 2007
- NCT00686985Lead sponsorPhase 2Sep 1, 2007
- NCT00002990Study chairPhase 3Mar 1, 1997
Details
- Founded
- 's-Hertogenbosch, NL Jan 1, 2011
- Last known activity
- Jan 1, 2024